Skip to main navigation Skip to search Skip to main content

Venetoclax plus hypomethylating agents as a bridge to transplant or donor lymphocyte infusion in relapsed/refractory acute myeloid leukemia

  • Radboud University Medical Center
  • Erasmus Medical Center
  • Leiden University Medical Center
  • University Medical Center Utrecht
  • Hagaziekenhuis, Den Haag, Netherlands
  • Amphia Hospital
  • Meander Medical Center
  • OLVG
  • Slingeland Hospital
  • Máxima Medical Centre
  • Sint Antonius Hospital
  • Catharina Hospital
  • Reinier de Graaf Group
  • Department of Radiation Oncology (MAASTRO), GROW Research Institute for Oncology and Reproduction, Maastricht University Medical Centre+
  • University Medical Center Groningen

Research output: Contribution to journalArticleAcademicpeer-review

6 Downloads (Pure)

Abstract

Not available.

Original languageEnglish
JournalHaematologica
DOIs
Publication statusE-pub ahead of print - 18 Sept 2025

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Venetoclax plus hypomethylating agents as a bridge to transplant or donor lymphocyte infusion in relapsed/refractory acute myeloid leukemia'. Together they form a unique fingerprint.

Cite this